Riverain Technologies will showcase its artificial intelligence solutions and enhancements at the now-virtual 2020 Radiological Society of North America Annual Meeting (RSNA).

December 2, 2020 — Riverain Technologies will showcase its artificial intelligence solutions and enhancements at the now-virtual 2020 Radiological Society of North America Annual Meeting (RSNA).

Radiologists spend a significant amount of time on mundane reporting and measurement processes.  ClearRead tools help overcome this based on increased automation and can help radiologists improve the efficiency of disease detection, diagnosis, reporting, and treatment.

RSNA visitors will experience how Riverain is harnessing the power of artificial intelligence (AI) and strategic partnerships to empower radiologists, advance radiology, and improve diagnostic imaging.

As part of the event, Riverain will:

  • Demonstrate the FDA-cleared and CE-marked ClearRead bone and vessel suppression AI tools that takes advantage of the latest innovations in AI.
  • Present a Featured Product Demo on Wednesday, December 2, at 2:00 p.m. CST, followed by a 10-minute Q&A session. RSNA Session Code FD14.
  • Present an on-demand Innovation Theater presentation with Thomas Frauenfelder, MD, University Hospital Zurich, as he explains ClearRead benefits and outcomes. RSNA Session Code IT15.
  • Present an on-demand AI Showcase presentation with leading thoracic radiologists who have deployed ClearRead in their daily, clinical workflows. They discuss how AI can aid in improving patient outcomes and reading experience and provide their insights on the future of AI in radiology. Guest speakers include Jared Christensen, MD, MBA, Duke Health; Peter Lafferty, MD, LucidHealth; and Terence Matalon, MD, Einstein Health Network. RSNA Session Code AI17.

“Traditionally, radiology has struggled with immense workloads.  The challenge continues to accelerate due to more patients and more imaging data per patient. Physician burnout is a recognized issue and will likely get worse. Sites are looking to offset these challenges with AI now,” said Steve Worrell, CEO at Riverain Technologies. “Riverain has expertise in thoracic radiology, partnerships across the industry, and AI-powered solutions to surround radiologists with everything they need to facilitate their reading processes. It’s our privilege to help make sure that every radiologist has the power to see clearly and decide confidently.”

For more information: www.riveraintech.com


Related Content

News | Radiology Business

March 12, 2026 — DelveInsight's has released its latest Diagnostic Imaging Equipment Market Insights report. The in ...

Time March 13, 2026
arrow
News | Enterprise Imaging

Mar. 9, 2026 — GE HealthCare recently announced that View, the viewer within the Genesis Radiology Workspace, has ...

Time March 12, 2026
arrow
News | Stroke

March 11, 2026 — Brainomix, a provider of AI-powered imaging tools for stroke and lung fibrosis, has announced the ...

Time March 11, 2026
arrow
News | HIMSS

March 9, 2026 — Fujifilm Healthcare Americas Corp. is showcasing how its latest AI-powered enterprise imaging solutions ...

Time March 10, 2026
arrow
News | FDA

Mar. 9, 2026 — GE HealthCare's View, the powerful viewer within the Genesis Radiology Workspace, has received 510(k) ...

Time March 09, 2026
arrow
News | HIMSS

March 5, 2026 — At the Health Information and Management Systems Society (HIMSS) Conference & Exhibition 2026 in Las ...

Time March 06, 2026
arrow
News | Radiology Business

March 5, 2026 — Cassling is now accepting applications for the 2026 Imaging for Impact Award, a national recognition ...

Time March 05, 2026
arrow
News | Radiation Oncology

March 4, 2026 — Lunit has announced that 21 studies featuring its AI solutions will be presented at the European ...

Time March 05, 2026
arrow
News | Ultrasound Women's Health

March 2, 2026 — Ultrasound AI, a provider of artificial intelligence applications for medical imaging, has received FDA ...

Time March 03, 2026
arrow
News | FDA

Feb. 26, 2026 — The U.S. Food and Drug Administration (FDA) has given 510(k) class II clearance of qXR-Detect, the ...

Time February 26, 2026
arrow
Subscribe Now